Mark J. Poznansky

Last updated
Mark J. Poznansky
CM OOnt
Mark J. Poznansky.jpg
Born (1946-04-25) April 25, 1946 (age 78)
Montreal, Quebec, Canada
Alma mater McGill University
Occupation(s)Scientist and Consultant
Website G2G Consulting Website

Spindle Website

Saved By Science Website

Mark J. Poznansky CM OOnt (born April 25, 1946) is a research scientist, science administrator and science blogger. He is the past president and CEO of the Ontario Genomics Institute (OGI) and was previously chair of the board of OGI, and the founder of G2G Consulting Inc. He is a member of the Order of Canada, a member of the Order of Ontario and was CEO, president and scientific director of Robarts Research Institute.

Contents

Education and early career history

Born in Montreal, Poznansky was educated at McGill University, receiving his PhD in Physiology in 1970. Poznansky completed his postdoctoral training in Biophysics at Harvard Medical School in 1972, [1] where he held the position of Lecturer in Biophysics until 1976. He also served as charge de recherche at the Collège de France in Paris from 1973 to 1974.

Poznansky returned to Canada in 1976, taking a position as associate professor of physiology at the University of Alberta in Edmonton. [2] Over the next 18 years, he rose to the rank of Professor and his laboratory developed an international reputation both the areas of cholesterol [3] and membrane biophysics [4] as well as enzyme replacement therapy [5] and the development of novel approaches to drug delivery. [6] In 1984, Poznansky moved on to become the associate dean of medicine at the University of Alberta in Edmonton, a position he held for 9 years.

Robarts Research Institute and the London years

In 1993, Poznansky arrived in London, Ontario, as president and scientific director of Robarts Research Institute. He presided over a period of growth, not only in funding and employment but in technology transfer as well. Under his helm from 1993 until 2007, Robarts Research Institute increased its staff from just over 100 to over 600. [7] Annual research funding increased from $10 million per year to over $40 million annually and the Institute spun out 7 different companies including one that was sold to GE Healthcare.

While at Robarts, Poznansky served as president and CEO of London-based Viron Therapeutics Inc. The company was able to bring a candidate drug to the start of Phase II and raised $20 million to support future research efforts.

He was among a group that founded the London Biotechnology Incubator Inc., [8] Ontario's first Life Sciences incubator. They were able to gain financial support to build a 50,000 sq. ft. facility in London. [9]

The rapid physical and staffing growth of the Institute led to major financial issues in 2007, necessitating the take-over of the Robarts by the University of Western Ontario. Poznansky stepped down as scientific director at that time.

G2G Consulting

In 2008, Poznansky founded G2G Consulting Inc., services such as program reviews, mediation, strategic planning, change management, leadership training and mentoring and management restructuring.

Poznansky developed a process to help the Spanish government support the life sciences industry. He worked with the Canada Foundation for Innovation. [10]

He helped form a research partnership made up of Robarts Research Institute, Merck & Co, Merck Frosst Canada and GE Healthcare [11] that was able to receive funding of $20 million over four years, resulting in many key research findings and publications on the subject of lung disease. Poznansky helped change the way the University of Alberta, Edmonton conducted research and helped facilitate the amalgamation of the research administration that occurred when Ottawa Civic and Ottawa General Hospitals merged to create The Ottawa Hospital. He also aided the Thunder Bay Regional Institute in attracting not only some of the "most respected health research minds in Canada" [12] but those from around the globe. [13]

Poznansky completed the negotiation and advanced negotiation workshops at the Harvard Negotiation Institute, Harvard Law School.

Ontario Genomics Institute

Poznansky was appointed as president and CEO of the Ontario Genomics Institute (OGI) on December 1, 2010. [14] He served in this capacity until August 1, 2017. [15] At OGI, Poznansky helped develop the Think Synthetic Biology campaign that identified the role that synthetic biology can play in advancing research for the wellbeing of Ontarians. [16]

Spindle

On August 1, 2017, Poznansky joined Spindle, a strategic consulting firm that focuses on life and health sciences innovation, as a member of its Senior Advisory Group. [17]

Saved By Science Website

In November 2019, Poznansky launched Saved By Science, a website at www.savedbyscience.org where he blogs on four subjects related to the world of science - the environment, food, health and politics/policy. [18] The website includes blogs on synthetic biology and climate change.

Saved By Science: The Hope and Promise of Synthetic Biology

On September 22, 2020, ECW Press released Saved By Science: The Hope and Promise of Synthetic Biology. [19] Kirkus Reviews said the book was "energetic and optimistic" and “shows how synthetic biology can be used to contend with major issues involving health, food, and the environment." [19] An excerpt of Saved By Science: The Hope and Promise of Synthetic Biology appeared in the Toronto Star on September 19, 2020 [20] and in Canadian Geographic on September 23, 2020 [21] Dr. Poznansky was interviewed about the book on September 22, 2020 on SXM Canada Talks [22] and the Gill Deacon Show on the Canadian Broadcasting Corporation English radio network.

Chairs and board memberships

Poznansky is Chair of Let's Talk Science, [23] Chief Science Advisor to the CEO of the Thunder Bay Regional Research Institute [24] and a board member of the Innovation Institute of Ontario.

Poznansky is a founding member and past Chair of the Council for Health Research in Canada, [25] a research advocacy group in Ottawa. He also chaired the Scientific Advisory Board of the Canadian Medical Discoveries Fund [8] and the board of MDS Capital Corp. [26]

He is a board member of the Consortium for the Barcode of Life. [27]

He has sat on the boards of organizations such as Diabetogen, BioMark Inc. and TechAlliance, London. Poznansky has also been a member of science-related committees including the Science Advisory Committee of the Heart and Stroke Foundation of Canada and the Medical Research Council of Canada Grants Panel. [28]

Guest lecturing

Poznansky lectures on subjects related to the biopharmaceutical industry and research and administration and funding, including technology transfer. He also lectures on Jewish medical ethics as it pertains to human and animal experimentation. [29]

In 2017, Dr. Poznansky lectured on the Scientific Revolution at the Dr. Louis Siminovitch Lecture Series. [30]

He discussed Genomics Hype and Hope at the 2018 Notable Speakers Series held in Toronto. [31]

Dr. Poznansky presented at a session at the 2019 Canadian Science Conference on: Policy Lessons in the Age of Technological Disruption. [32]

Other accomplishments

In 2005, Poznansky was made a member of the Order of Canada [33] and a member of the Order of Ontario. [34] He is also the recipient of the Queen Elizabeth II Golden Jubilee Medal. [8]

Poznansky led the development of the book Using Our Heads, "a celebration of innovation that was supported by the Ontario Innovation Trust (OIT)." [35]

He is one of the founders of the Canadian Medical Hall of Fame, and served on its board of directors from 1994 to 2001. [36]

Other books

Related Research Articles

<span class="mw-page-title-main">Craig Venter</span> American Scientist

John Craig Venter is an American scientist. He is known for leading one of the first draft sequences of the human genome and led the first team to transfect a cell with a synthetic chromosome. Venter founded Celera Genomics, the Institute for Genomic Research (TIGR) and the J. Craig Venter Institute (JCVI). He was the co-founder of Human Longevity Inc. and Synthetic Genomics. He was listed on Time magazine's 2007 and 2008 Time 100 list of the most influential people in the world. In 2010, the British magazine New Statesman listed Craig Venter at 14th in the list of "The World's 50 Most Influential Figures 2010". In 2012, Venter was honored with Dan David Prize for his contribution to genome research. He was elected to the American Philosophical Society in 2013. He is a member of the USA Science and Engineering Festival's advisory board.

<span class="mw-page-title-main">Shirley M. Tilghman</span> Canadian molecular biologist and president emerita of Princeton University

Shirley Marie Tilghman, is a Canadian scholar in molecular biology and an academic administrator. She is now a professor of molecular biology and public policy and president emerita of Princeton University. In 2002, Discover magazine recognized her as one of the 50 most important women in science.

<span class="mw-page-title-main">Lakehead University</span> University in Thunder Bay, and Orillia, Ontario, Canada

Lakehead University is a public research university with campuses in Thunder Bay and Orillia, Ontario, Canada. Lakehead University, shortened to 'Lakehead U', is non-denominational and provincially supported. It has undergraduate programs, graduate programs, the Bora Laskin Faculty of Law, the only internationally accredited (AACSB) business school in northern Ontario, and is home to the western campus of the Northern Ontario School of Medicine.

<span class="mw-page-title-main">Lap-Chee Tsui</span> Hong Kong academic

Lap-Chee Tsui is a Chinese-born Canadian geneticist and served as the 14th Vice-Chancellor and President of the University of Hong Kong.

Joseph Louis Rotman,, was a noted Canadian businessman and philanthropist. Rotman was the founder, benefactor and member of many successful organizations, such as the Clairvest Group Inc., the Rotman Research Institute, the Rotman School of Management, and the Rotman Institute of Philosophy. Throughout his life, he received three honorary degrees, as well as an induction into the Canadian Business Hall of Fame. He is well-regarded for donating his time and financial assistance to numerous philanthropic causes including the arts, education and healthcare.

<span class="mw-page-title-main">Robarts Research Institute</span> Canadian university medical institute

The Robarts Research Institute is a medical research institute at the University of Western Ontario, as part of the Schulich School of Medicine and Dentistry. Staff scientists work to investigate a range of diseases including heart disease, stroke, diabetes, Alzheimer's disease, and cancer.

<span class="mw-page-title-main">Wistar Institute</span> American biomedical research institute

The Wistar Institute is an independent, nonprofit research institution in biomedical science with special focuses in oncology, immunology, infectious disease, and vaccine research. Located on Spruce Street in the University City section of Philadelphia, Wistar was founded in 1892 as a nonprofit institution to focus on biomedical research and training.

Arthur D. Levinson is an American businessman and is the chairman of Apple Inc. (2011–present) and chief executive officer (CEO) of Calico. He is the former CEO (1995–2009) and chairman (1999–2014) of Genentech.

George Henry Poste, CBE FRS, is a former director of the Biodesign Institute at Arizona State University.

<span class="mw-page-title-main">Piers Nash</span>

Piers David Nash is an entrepreneur, cancer biology professor, data evangelist, writer and technology futurist. He is the founder of Sympatic, and the son of academic Roger Nash.

Expenditures by Canadian universities on scientific research and development accounted for about 40% of all spending on scientific research and development in Canada in 2006.

The Centre for Applied Genomics is a genome centre in the Research Institute of The Hospital for Sick Children, and is affiliated with the University of Toronto. TCAG also operates as a Science and Technology Innovation Centre of Genome Canada, with an emphasis on next-generation sequencing (NGS) and bioinformatics support. Research at TCAG focuses on the genetic and genomic basis of human variability, health and disease, including research on the genetics of autism spectrum disorder and structural variation of the human genome. The centre is located in the Peter Gilgan Centre for Research and Learning in downtown Toronto, Canada.

This article outlines the history of natural scientific research in Canada, including physics, astronomy, space science, geology, oceanography, chemistry, biology, and medical research. Neither the social sciences nor the formal sciences are treated here.

<span class="mw-page-title-main">California Institute for Quantitative Biosciences</span>

The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three University of California campuses in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.

<span class="mw-page-title-main">Ontario Genomics</span>

Ontario Genomics, formerly the Ontario Genomics Institute, is a not-for-profit organization that manages genomics research projects and platforms. Ontario Genomics is funded by the Ontario government and the federal research agency Genome Canada.

Peter Goodhand is a senior executive and board member in the health research advancement community.

<span class="mw-page-title-main">Gregory L. Verdine</span> American chemical biologist

Gregory L. Verdine is an American chemical biologist, biotech entrepreneur, venture capitalist and university professor. He is a founder of the field of chemical biology, which deals with the application of chemical techniques to biological systems. His work has focused on mechanisms of DNA repair and cell penetrability.

Shenzhen International BT Leadership Summit is a biology-focused business conference. It is held each year in September. It is arranged by the Shenzhen Municipal People's Government. It is held at the Shenzhen Convention and Exhibition Center.

Srinivasan Ramachandran is an Indian biologist, bioinformatician and a senior principal scientist at the department of genome analysis of the Institute of Genomics and Integrative Biology. Known for his studies in the field of data analytics, Ramachandran is also an adjunct faculty, senior Principal Scientist and AcSIR Professor at the Faculty of Biological Sciences of the Indian Institute of Technology, Delhi. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2007.

Rebecca Jane Rylett is a Canadian molecular neurobiologist. As of 2019, she is the Scientific Director of the CIHR Institute of Aging. As a Distinguished University Professor at the University of Western Ontario, Rylett also served as an Associate Dean in the Schulich School of Medicine & Dentistry and chair of the Department of Physiology and Pharmacology.

References

  1. ↑ "Board of Directors". www.ontariogenomics.ca. Archived from the original on September 5, 2012.
  2. ↑ "Press release on Mark Poznansky by Thunder Bay Regional Research Institute that presents biographical information including a discussion of his stints at University of Alberta and Harvard" (PDF). Archived from the original (PDF) on 2011-07-16. Retrieved 2009-11-17.
  3. ↑ Poznansky, Mark; Lange, Yvonne (February 28, 1976). "Transbilayer movement of cholesterol in dipalmitoyllecithin–cholesterol vesicles". Nature. 259 (5542): 420–422. Bibcode:1976Natur.259..420P. doi:10.1038/259420a0. PMID   1250389. S2CID   9321598 – via www.nature.com.
  4. ↑ Regulation of human red cell volume by linked cation fluxes published in Journal of Membrane Biology, Volume 10, Number 1/December, 1972, Page 259-266
  5. ↑ Enzyme-Albumin Polymers: New Approaches to the Use of Enzymes in Medicine published in Artificial Cells, Blood Substitutes, and Biotechnology, Volume 15, Issue 4 January 1987, Pages 751 - 774
  6. ↑ Thomas, Panakkezhum D.; Poznansky, Mark J. (1990). "A modified tetramethylbenzidine method for measuring lipid hydroperoxides". Analytical Biochemistry. 188: 228–232. doi:10.1016/0003-2697(90)90557-P.
  7. ↑ "Bioportfolio on Robarts Research Institute". Archived from the original on 2010-04-11. Retrieved 2009-11-06.
  8. 1 2 3 "Robarts president awarded Queens Golden Jubi".
  9. ↑ University of Western Ontario press release
  10. ↑ "Link provided on web page to download list of participants where Poznansky is listed". www.innovation.ca.
  11. ↑ "Canada's most powerful MRI device installed in London".
  12. ↑ Home page from TBRI
  13. ↑ Regional Bioscience Spotlight: Thunder Bay.
  14. ↑ "Dr. Mark J. Poznansky Appointed as President and CEO of the Ontario Genomics Institute | Ontario Genomics Institute". Archived from the original on 2011-10-04. Retrieved 2011-04-25.
  15. ↑ "Stocks". Bloomberg News . 20 June 2023.
  16. ↑ http://www.ontariogenomics.ca/syntheticbiology/Ontario_Synthetic_Biology_Report_2016.pdf [ bare URL PDF ]
  17. ↑ "Our Team - Spindle Strategy". 17 May 2022.
  18. ↑ "Blog". www.savedbyscience.org.
  19. 1 2 "SAVED BY SCIENCE". www.kirkusreviews.com.
  20. ↑ "Mark J. Poznansky, author of new book 'Saved by Science,' says synthetic biology may be the hope for mankind's future | The Star". Toronto Star . 19 September 2020.
  21. ↑ "Excerpt from Saved by Science: The Hope and Promise of Synthetic Biology".
  22. ↑ @CanadaTalks167 (September 22, 2020). ". @TheBreakdown167 w/ @allisondore & @Cassandra___B is LIVE from 2-4pmET! Today @JudyPenzSheluk on @crimewriterscan Awards of Excellence & this months releases; @raffpylon on his single 'King's Lane' & @amnesty fundraiser; plus we'll talk to Dr. Mark J. Poznansky @saved_byscience" (Tweet) – via Twitter.
  23. ↑ "Board listing of Let's Talk Science".
  24. ↑ "Article on Dr. Mark Poznansky joining the Thunder Bay Regional Research Institute". Archived from the original on 2011-07-24. Retrieved 2009-11-17.
  25. ↑ "Evidence - FINA (36-1) - No. 28 - House of Commons of Canada". www.ourcommons.ca.
  26. ↑ "McGill announcement". Archived from the original on 2011-05-15. Retrieved 2017-09-04.
  27. ↑ "Mark Poznansky - iBOL Board Member". ibol.org.
  28. ↑ Dr. Mark Poznansky Executive Profile at BusinessWeek.
  29. ↑ Jewish ethics viewed as helpful in medicine by Mara Koven, published in The Canadian Jewish News February 3, 1994, Page 20
  30. ↑ "The Scientific Revolution with Dr. Mark Poznansky | UJA Federation of Greater Toronto". jewishtoronto.com.
  31. ↑ "Notable Speakers Series: Dr. Mark J. Poznansky on Apr 16th 2018 1:00pm". www.beth-tzedec.org.
  32. ↑ "CSPC 2019 Schedule". cspc2019.sched.com.
  33. ↑ "Article on Order of Canada appointments being announced". Archived from the original on December 18, 2005.
  34. ↑ "Article on Dr. Mark J. Poznansky being appointed a member of the Order of Ontario". Archived from the original on 2011-05-15. Retrieved 2017-09-04.
  35. ↑ "The people behind Using Our Heads". Archived from the original on 2010-04-25. Retrieved 2009-11-07.
  36. ↑ https://www.cdnmedhall.org/sites/default/files/history_of_cmhf_-_final.pdf [ bare URL PDF ]
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.